scPharmaceuticals Statistics
Total Valuation
SCPH has a market cap or net worth of $139.54 million. The enterprise value is $115.55 million.
Important Dates
The last earnings date was Wednesday, March 19, 2025, after market close.
| Earnings Date | Mar 19, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
SCPH has 50.28 million shares outstanding. The number of shares has increased by 15.59% in one year.
| Current Share Class | 50.28M |
| Shares Outstanding | 50.28M |
| Shares Change (YoY) | +15.59% |
| Shares Change (QoQ) | +14.83% |
| Owned by Insiders (%) | 6.57% |
| Owned by Institutions (%) | 49.77% |
| Float | 26.89M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 3.40 |
| Forward PS | 1.74 |
| PB Ratio | 10.44 |
| P/TBV Ratio | 10.48 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Financial Ratio HistoryEnterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | 3.18 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 7.12, with a Debt / Equity ratio of 3.96.
| Current Ratio | 7.12 |
| Quick Ratio | 5.94 |
| Debt / Equity | 3.96 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -8.56 |
Financial Efficiency
Return on equity (ROE) is -336.97% and return on invested capital (ROIC) is -56.43%.
| Return on Equity (ROE) | -336.97% |
| Return on Assets (ROA) | -40.08% |
| Return on Invested Capital (ROIC) | -56.43% |
| Return on Capital Employed (ROCE) | -69.92% |
| Revenue Per Employee | $267,147 |
| Profits Per Employee | -$626,088 |
| Employee Count | 136 |
| Asset Turnover | 0.36 |
| Inventory Turnover | 1.00 |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -44.83% in the last 52 weeks. The beta is 0.39, so SCPH's price volatility has been lower than the market average.
| Beta (5Y) | 0.39 |
| 52-Week Price Change | -44.83% |
| 50-Day Moving Average | 3.23 |
| 200-Day Moving Average | 4.01 |
| Relative Strength Index (RSI) | 34.45 |
| Average Volume (20 Days) | 636,975 |
Short Selling Information
The latest short interest is 6.14 million, so 12.22% of the outstanding shares have been sold short.
| Short Interest | 6.14M |
| Short Previous Month | 5.61M |
| Short % of Shares Out | 12.22% |
| Short % of Float | 22.84% |
| Short Ratio (days to cover) | 9.55 |
Income Statement
In the last 12 months, SCPH had revenue of $36.33 million and -$85.15 million in losses. Loss per share was -$1.91.
| Revenue | 36.33M |
| Gross Profit | 24.97M |
| Operating Income | -64.78M |
| Pretax Income | -57.71M |
| Net Income | -85.15M |
| EBITDA | -64.76M |
| EBIT | -64.78M |
| Loss Per Share | -$1.91 |
Full Income StatementBalance Sheet
The company has $76.68 million in cash and $52.69 million in debt, giving a net cash position of $23.98 million or $0.48 per share.
| Cash & Cash Equivalents | 76.68M |
| Total Debt | 52.69M |
| Net Cash | 23.98M |
| Net Cash Per Share | $0.48 |
| Equity (Book Value) | 13.32M |
| Book Value Per Share | 0.27 |
| Working Capital | 90.97M |
Full Balance SheetCash Flow
In the last 12 months, operating cash flow was -$70.54 million and capital expenditures -$21,000, giving a free cash flow of -$70.56 million.
| Operating Cash Flow | -70.54M |
| Capital Expenditures | -21,000 |
| Free Cash Flow | -70.56M |
| FCF Per Share | -$1.40 |
Full Cash Flow StatementMargins
Gross margin is 68.73%, with operating and profit margins of -178.29% and -234.36%.
| Gross Margin | 68.73% |
| Operating Margin | -178.29% |
| Pretax Margin | -234.36% |
| Profit Margin | -234.36% |
| EBITDA Margin | -178.23% |
| EBIT Margin | -178.29% |
| FCF Margin | n/a |
Dividends & Yields
SCPH does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -15.59% |
| Shareholder Yield | -15.59% |
| Earnings Yield | -61.02% |
| FCF Yield | -50.57% |
Analyst Forecast
The average price target for SCPH is $14.00, which is 404.51% higher than the current price. The consensus rating is "Strong Buy".
| Price Target | $14.00 |
| Price Target Difference | 404.51% |
| Analyst Consensus | Strong Buy |
| Analyst Count | 3 |
| Revenue Growth Forecast (5Y) | 52.69% |
| EPS Growth Forecast (5Y) | n/a |
Stock ForecastsStock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
SCPH has an Altman Z-Score of -4.19 and a Piotroski F-Score of 3. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | -4.19 |
| Piotroski F-Score | 3 |